PainReform
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Public
- Established
- 2007-01-01
- Employees
- 7
- Market Cap
- $1.9M
- Website
- http://www.painreform.com
- Introduction
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The company was founded by Lihu Avitov and Dan Teleman in 2007 and...
Initial Topline Data for PRF-110 Phase 3 Clinical Trial Announced by PainReform
PainReform Ltd. announced partial topline data from its Phase 3 trial of PRF-110, showing statistically significant pain reduction over placebo in the first 48 hours post-bunionectomy surgery. However, data for the subsequent 24 hours is unclear, necessitating collaboration with Lotus Clinical Research to resolve issues. PRF-110, an extended-release ropivacaine formulation, aims to provide prolonged pain relief and reduce opioid use.
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial
PainReform Ltd. announced partial Phase 3 data for PRF-110, showing significant pain reduction in the first 48 hours post-bunionectomy, but data for the subsequent 24 hours is unclear. The company is working with Lotus Clinical Research to resolve the issue.
PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110
PainReform Ltd. announced positive findings on PRF-110's compatibility with sutures, suggesting no impact on mechanical properties of PROLENE™ and Vicryl™ sutures, crucial for post-surgical pain relief.
© Copyright 2024. All Rights Reserved by MedPath